Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Sabo
J A
JA
Fairview-University Medical Center, St Paul, Minn, USA.
Nord
C P
CP
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003376:Counseling; D003422:Critical Care / Q000379:methods; D019091:Critical Pathways; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000451:nursing; D007262:Infusions, Intravenous; D008875:Middle Aged; D010347:Patient Care Planning; D010353:Patient Education as Topic; D018579:Patient Selection; D015995:Prevalence
D000959:Antihypertensive Agents; D011464:Epoprostenol